α-noradrenergic receptor modulation of the phencyclidine- and Δ9- tetrahydrocannabinol-induced increases in dopamine utilization in rat prefrontal cortex

Synapse

Volumn 28, Issue 1, 1998, Pages 21-26

  Jentsch, J David ^a   Wise, Alyssa ^a   Katz, Zachary ^a   Roth, Robert H ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clonidine; Guanfacine; Nucleus accumbens; Prazosin; Psychotomimetic

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; CLONIDINE; DRONABINOL; GUANFACINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE; PRAZOSIN; PSYCHEDELIC AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; DOPAMINE; DOPAMINE UPTAKE INHIBITOR; TETRAHYDROCANNABINOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG INDUCED DISEASE; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOSIS; RAT; REGULATORY MECHANISM; SCHIZOPHRENIA; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; SPRAGUE DAWLEY RAT;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; CLONIDINE; DOPAMINE; DOPAMINE UPTAKE INHIBITORS; GUANFACINE; HALLUCINOGENS; MALE; NUCLEUS ACCUMBENS; PHENCYCLIDINE; PRAZOSIN; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA; TETRAHYDROCANNABINOL;

EID: 0344262258     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199801)28:1<21::AID-SYN3>3.0.CO;2-E     Document Type: Article

References (42)

1. Bowers, M.B., and Hoffman, F.J. (1984) Homovanillic acid in rat caudate and prefrontal cortex following phencyclidine and amphetamine. Psychopharmacology, 84:136-137.
2. 9THC and cocaine. Brain Res., 366:405-407.
3. Boyce, S., Rupniak, N.M.J., Steventon, M.J., Cook, G., and Iversen, S.D. (1991) Psychomotor activity and cognitive disruption attributable to NMDA, but not sigma, interactions in primates. Behav. Brain Res., 42:115-121.
4. Brozoski, T.J., Brown, R.M., Rosvold, H.E., and Goldman, P.S. (1979) Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science, 205:929-931.
5. Bubser, M., and Schmidt, W.J. (1990) 6-OHDA lesions of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze. Behav. Brain Res., 37:157-168.
6. Bylund, D.B. (1985) Heterogeneity of alpha-2 adrenergic receptors. Pharmacol. Biochem. Behav., 22:835-843.
7. Carlsson, A. (1988) The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology, 20:379-382.
8. 9-tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex. Eur. J. Pharmacol., 190:259-262.
9. Davis, K.L., Kahn, R.S., Ko, G., and Davidson, M. (1990) Dopamine in schizophrenia: a review and reconceptualization. Am. J. Psychiatry, 148:1474-1486.
10. Deutch, A.Y., and Roth, R.H. (1990) The determinants of stress-induced activation of the prefrontal cortical dopamine system. In: The Prefrontal Cortex: Its Structure, Function and Pathology. H.B.M. Vylings, C.G.V. Eden, J.P.C. DeBruim, M.A. Corner, and M.G.P. Feenstra, eds. Elsevier, Amsterdam, pp. 367-403.
11. Deutch, A. Y., Tam, S.Y., Freeman, A.S., Bowers, M.B., and Roth, R.H. (1987) Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to sttiatal response. Eur. J. Pharmacol., 134:257-264.
12. Ferraro, D.P. (1980) Acute effects of marijuana on human memory and cognition. NIDA Res. Monogr. 31:98-119.
13. Freedman, A.S., and Bunney, B.S. (1984) The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity. Eur. J. Pharmacol., 104:287-293.
14. French, E.D. (1994) Phencyclidine and the midbrain dopamine system: electrophysiology and behavior. Neurotoxicol. Teratol., 16:355-362.
15. French, E.D., Dillon, K., and Wu, X. (1997) Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra. Neuroreport 8:649-652.
16. Goldman-Rakic, P.S. (1987) Circuitry of the frontal cortex and the regulation of behavior by representational knowledge. In: Handbook of Physiology. Vol. V. The Nervous System. F. Plum and V. Mount-castle, eds. American Physiological Society, Bethesda, pp. 373-417.
17. Goldman-Rakic, P.S. (1991) Prefrontal cortical dysfunction in schizophrenia: the relevance of working memory. In: Psychopathology and the Brain. B.J. Carroll and J.E. Barrett, eds. Raven Press, New York, pp. 1-23.
18. Goldman-Rakic, P.S., Bergson, C., Mrzljak, L., and Williams, G.V. (1997) Dopamine receptors and cognitive function in nonhuman primates. In: The Dopamine Receptors. K.A. Neve and R.L. Neve, eds. Humana Press, Tucson, AZ, pp. 499-522.
19. Grenhoff, J., and Svensson, T.H. (1989) Clonidine modulates dopamine cell firing in rat ventral tegmental area. Eur. J. Pharmacol., 165:11-18.
20. Grenhoff, J., and Svensson, T.H. (1993) Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area. Eur. J. Pharmacol., 233:79-84.
21. Grenhoff, J., Nisell, M., Ferre, S., Aston-Jones, G., and Svensson, T.H. (1993) Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J. Neural Transm. [Gen. Sect.], 93:11-25.
22. Gresch, P.J., Sved, A.F., Zigmond, M.J., and Finlay, J.M. (1995) Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J. Neurochem., 65:111-116.
23. Hertel, P., Mathe, J.M., Nomikos, G.G., Iurlo, M., Mathe, A.A., and Svensson, T.H. (1996) Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the rat. Behav. Brain Res., 72:103-114.
24. Herve, D., Blanc, G., Glowinski, J., and Tassin, J.P. (1982) Reduction of dopamine utilization in the prefrontal cortex but not in the nucleus accumbens after selective destruction of noradrenergic fibers innervating the ventral tegmental area in the rat. Brain Res., 237:510-516.
25. Javitt, D.C., and Zukin, S.R. (1991) Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiatry, 148:1301-1308.
26. Jentsch, J.D., Elsworth, J.D., Redmond, D.E., and Roth, R.H. (1997a) Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966. J. Neurosci., 17:1769-1776.
27. 9-tetrahydrocannabinol increases prefrontal cortical catecholaminergic turnover and impairs spatial working memory in the rat: Blockade of dopaminergic effects with HA966. Neuropsychopharmacology, 16:426-432.
28. Krystal, J.H., Karper, L.P., Seibyl, J.P., Freeman, G.K., Delaney, R., Bremner, J.D., Heninger, G.R., Bowers, M.B., and Charney, D.S. (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive and neuroendocrine responses. Arch. Gen. Psychiatry, 51:199-214.
29. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem., 193:265-275.
30. 9-tetrahydrocannabinol on short-term memory in the rat. Physiol. Behav., 57:177-179.
31. Morrow, B.A., George, T.P., Lee, E.J.K., and Roth, R.H. (1996) Noradrenergic α-2 agonists diminish behavioral and dopaminergic responses to conditioned fear. Soc. Neurosci. Abstr. 22:2063.
32. Murphy, B.L., Arnsten, A.F.T., Goldman-Rakic, P.S., and Roth, R.H. (1996a) Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc. Natl. Acad. Sci. U.S.A., 93:1325-1329.
33. Murphy, B.L., Arnsten, A.F.T., Jentsch, J.D., and Roth, R.H. (1996b) Dopamine and spatial working memory in rats and monkeys: pharmacological antagonism of stress-induced impairment. J. Neurosci. 16:7768-7775.
34. 9-tetrahydrocannabinol (THC) on memory in the rat. Drug Alcohol Dep., 28:167-175.
35. Pawlowski, L., Mathe, J.M., and Svensson, T.H. (1990) Phencyclidine activates rat AlO dopamine neurons but reduces burst activity and causes regularization.Acta Physiol. Scand. 139:529-530.
36. Roth, R.H., and Elsworth, J.D. (1995) Biochemical pharmacology of midbrain dopamine neurons. In: Psychopharmacology, the Fourth Generation of Progress. F.E. Bloom and D.J. Kupfer, eds. Raven Press, New York, pp. 227-243.
37. Sawaguchi, T., and Goldman-Rakic, P.S. (1991) D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science, 251:947-950.
38. Simon, H., Scatton, B., and LeMoal, M. (1980) Dopaminergic A10 neurons are involved in cognitive functions. Nature, 286:150-151.
39. Sirvio, J., Riekkinen, P., Jr., Vajanto, I., Koivisto, E., and Riekkinen, P. (1991) The effect of guanfacine, α2 agonist, on the performance of young and aged rats in a spatial navigation task. Behav. Neural Biol. 56:101-107.
40. Tam, S.Y. (1986) Mesoprefrontal dopamine neurons: studies on their regulatory control. Doctoral Thesis, Yale University, New Haven, Connecticut
41. Thacore, V.R., and Shukla, S.R. (1976) Cannabis psychosis and paranoid schizophrenia. Arch. Gen. Psychiatry, 33:383-386.
42. Verma, A., and Moghaddam, B. (1996) NMDA receptor antagonists impair prefrontal cortical function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. J. Neurosci., 16:373-379.